全文获取类型
收费全文 | 1074篇 |
免费 | 69篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 33篇 |
妇产科学 | 14篇 |
基础医学 | 106篇 |
口腔科学 | 18篇 |
临床医学 | 114篇 |
内科学 | 187篇 |
皮肤病学 | 16篇 |
神经病学 | 81篇 |
特种医学 | 163篇 |
外科学 | 162篇 |
综合类 | 17篇 |
预防医学 | 54篇 |
眼科学 | 18篇 |
药学 | 44篇 |
肿瘤学 | 120篇 |
出版年
2022年 | 11篇 |
2021年 | 18篇 |
2020年 | 12篇 |
2019年 | 17篇 |
2018年 | 15篇 |
2017年 | 15篇 |
2016年 | 19篇 |
2015年 | 19篇 |
2014年 | 24篇 |
2013年 | 46篇 |
2012年 | 41篇 |
2011年 | 39篇 |
2010年 | 43篇 |
2009年 | 40篇 |
2008年 | 25篇 |
2007年 | 28篇 |
2006年 | 29篇 |
2005年 | 20篇 |
2004年 | 33篇 |
2003年 | 23篇 |
2002年 | 22篇 |
2001年 | 32篇 |
2000年 | 22篇 |
1999年 | 22篇 |
1998年 | 36篇 |
1997年 | 32篇 |
1996年 | 39篇 |
1995年 | 29篇 |
1994年 | 26篇 |
1993年 | 25篇 |
1992年 | 16篇 |
1991年 | 21篇 |
1990年 | 17篇 |
1989年 | 33篇 |
1988年 | 24篇 |
1987年 | 27篇 |
1986年 | 22篇 |
1985年 | 23篇 |
1984年 | 17篇 |
1983年 | 12篇 |
1982年 | 13篇 |
1981年 | 12篇 |
1980年 | 6篇 |
1979年 | 14篇 |
1978年 | 12篇 |
1977年 | 22篇 |
1976年 | 13篇 |
1975年 | 15篇 |
1972年 | 4篇 |
1970年 | 3篇 |
排序方式: 共有1151条查询结果,搜索用时 15 毫秒
51.
52.
53.
54.
Role of COX-2 in epithelial–stromal cell interactions and progression of ductal carcinoma in situ of the breast
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Min Hu Guillermo Peluffo Haiyan Chen Rebecca Gelman Stuart Schnitt Kornelia Polyak 《Proceedings of the National Academy of Sciences of the United States of America》2009,106(9):3372-3377
Epithelial–stromal cell interactions have an important role in breast tumor progression, but the molecular mechanisms underlying these effects are just beginning to be understood. We previously described that fibroblasts promote, whereas normal myoepithelial cells inhibit, the progression of ductal carcinoma in situ (DCIS) to invasive breast carcinomas by using a xenograft model of human DCIS. Here, we report that the tumor growth and progression-promoting effects of fibroblasts are at least in part due to increased COX-2 expression in tumor epithelial cells provoked by their interaction with fibroblasts. Up-regulation of COX-2 in DCIS xenografts resulted in increased VEGF and MMP14 expression, which may contribute to the larger weight and invasive histology of COX-2-expressing tumors. Administration of celecoxib, a selective COX-2 inhibitor, to tumor-bearing mice decreased xenograft tumor weight and inhibited progression to invasion. Coculture of fibroblasts with DCIS epithelial cells enhanced their motility and invasion, and this change was associated with increased MMP14 expression and MMP9 protease activity. We identified the NF-κB pathway as one of the mediators of stromal fibroblast-derived signals regulating COX-2 expression in tumor epithelial cells. Inhibition of NF-κB and COX-2 activity and down-regulation of MMP9 expression attenuated the invasion-promoting effects of fibroblasts. These findings support a role for COX-2 in promoting the progression of DCIS to invasive breast carcinomas, and suggest that therapeutic targeting of the NF-κB and prostaglandin signaling pathways might be used for the treatment and prevention of breast cancer. 相似文献
55.
Scott L. Letendre Jennifer Marquie-Beck Ronald J. Ellis Steven Paul Woods Brookie Best David B. Clifford Ann C. Collier Benjamin B. Gelman Christina Marra Justin C. McArthur J. Allen McCutchan Susan Morgello David Simpson Terry J. Alexander Janis Durelle Robert Heaton Igor Grant 《Journal of neuroimmune pharmacology》2007,2(1):120-127
Background Effective antiretroviral therapy (ART) has reduced the incidence of HIV-associated neurocognitive impairment (HNCI) but its
prevalence remains high. Clinical trials have yet to identify a consistently effective treatment for HNCI, other than ART,
but in vitro data support that some drugs approved by the Food and Drug Administration (FDA) for other indications might benefit
individuals with HNCI. Some of these drugs, such as serotonin reuptake inhibitors (SRIs) and HMG-CoA reductase inhibitors
(statins), may do so by reducing HIV replication in the CNS and are already widely used by HIV-infected individuals.
Methods Six-hundred fifty-eight HIV-infected participants of the CHARTER cohort had a baseline assessment, which included comprehensive
neuropsychological (NP) testing and HIV RNA measurements in plasma and cerebrospinal fluid (CSF). Four-hundred sixty-seven
(71%) subjects used ART, 195 (30%) used SRIs, and 63 (10%) used statins.
Results SRI users were less likely to have HIV RNA levels in CSF above 50 copies (c)/mL (29 vs. 37% in non-SRI users, OR 0.69, p = 0.05). This association was most evident for three of the seven SRIs (citalopram, sertraline, and trazodone, or “antiviral”
SRIs, combined 25 vs. 38% in non-SRI users, OR 0.56, p = 0.01) and was strongest in those not taking concomitant ART (61 vs. 83%, OR 0.31, p = 0.01). “Antiviral” SRI users also performed better on NP tests (median global deficit score 0.37 vs. 0.47, p = 0.04). Statin users were also less likely to have HIV RNA levels in CSF above 50 c/mL (16 vs. 37%, p < 0.001) but, in contrast to SRIs, the association was strongest in those taking ART (2 vs. 18%, p < 0.001). Statin use was not associated with better NP performance. Multivariate analyses indicated that the use of “antiviral”
SRIs—but not statins—was associated with undetectable HIV RNA levels in CSF and better NP performance.
Conclusions SRIs may reduce HIV replication in CSF and improve NP performance. This was particularly true for three SRIs—supporting differences
in antiviral efficacy between drugs—in individuals who were not taking ART. In contrast, statins were not associated with
lower HIV replication in CSF in multivariate analyses and were not associated with better NP performance. These analyses support
the value of large observational cohort studies in identifying FDA-approved drugs that may be worth further investigation. 相似文献
56.
Etemad-Moghadam B Rhone D Steenbeke T Sun Y Manola J Gelman R Fanton JW Racz P Tenner-Racz K Axthelm MK Letvin NL Sodroski J 《Vaccine》2002,20(15):1934-1937
The efficacy of candidate AIDS vaccines to mediate protection against viral infection and pathogenesis is evaluated, at a preclinical stage, in animal models. One model that is favored because the infecting virus is closely related to HIV-1 and because of the rapidity of pathogenic outcomes is the infection of Old World monkeys by simian-human immunodeficiency virus (SHIV) chimerae. We investigated the basis for the depletion of CD4(+) T lymphocytes in a SHIV-macaque model. Molecularly cloned SHIVs, SHIV-89.6 and SHIV-KB9, differ in the ability to cause CD4(+) T-cell loss at a given level of virus replication in monkeys. The envelope glycoproteins of the pathogenic SHIV-KB9 mediate membrane-fusion in cultured T lymphocytes more efficiently than the envelope glycoproteins of the non-pathogenic SHIV-89.6. The minimal envelope glycoprotein region that specifies this increase in membrane-fusing capacity was sufficient to convert SHIV-89.6 into a virus that causes profound CD4(+) T-cell depletion in monkeys. Conversely, two single amino acid changes that decrease the membrane-fusing ability of the SHIV-KB9 envelope glycoproteins also attenuated the CD4(+) T-cell destruction that accompanied a given level of virus replication in SHIV-infected monkeys. Thus, the ability of the HIV-1 envelope glycoproteins to fuse membranes, which has been implicated in the induction of viral cytopathic effects in vitro, contributes to the capacity of the pathogenic SHIV to deplete CD4(+) T lymphocytes in vivo. 相似文献
57.
58.
Phorbol ester-sensitive EL4 murine thymoma cells respond to phorbol 12-
myristate 13-acetate with activation of ERK mitogen-activated protein
kinases, synthesis of interleukin-2, and death, whereas phorbol ester-
resistant variants of this cell line do not exhibit these responses.
Additional aspects of the resistant phenotype were examined, using a
newly-established resistant cell line. Phorbol ester induced morphological
changes, ERK activation, calcium-dependent activation of the c-Jun
N-terminal kinase (JNK), interleukin-2 synthesis, and growth inhibition in
sensitive but not resistant cells. A series of protein kinase C activators
caused membrane translocation of protein kinase C's (PKCs) alpha, eta, and
theta in both cell lines. While PKC eta was expressed at higher levels in
sensitive than in resistant cells, overexpression of PKC eta did not
restore phorbol ester-induced ERK activation to resistant cells. In
sensitive cells, PKC activators had similar effects on cell viability and
ERK activation, but differed in their abilities to induce JNK activation
and interleukin-2 synthesis. PD 098059, an inhibitor of the mitogen
activated protein (MAP)/ERK kinase kinase MEK, partially inhibited ERK
activation and completely blocked phorbol ester-induced cell death in
sensitive cells. Thus MEK and/or ERK activation, but not JNK activation or
interleukin-2 synthesis, appears to be required for phorbol ester-induced
toxicity. Alterations in phorbol ester response pathways, rather than
altered expression of PKC isoforms, appear to confer phorbol ester
resistance to EL4 cells.
相似文献
59.
The present report describes psychobiological studies of behavior around the time of birth. An adaptive, ecological perspective is presented in which stimulation of the fetus and newborn is purported to instigate adaptive postpartum behavior. Studies describing the perinatal sensory environment are reviewed, with a consideration of emergent sensory function of the fetus. It is asserted that afferent input associated with parturition perturbs the fetus and neonate, producing a general arousal state that facilitates breathing, suckling, and early learning. The view developed herein is that perinatal sensory input induces and canalizes the newborn's behavior, thereby regulating adaptive postpartum function. Deviations in afferent input may alter ontogenetic trajectories and compromise developmental outcome by reducing availability of conditions necessary for adequate postpartum adaptation. 相似文献
60.